STOCK TITAN

Sema4 to Participate at Two Upcoming Investor Conferences in September

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Sema4 (Nasdaq: SMFR) announced participation in two upcoming virtual investor conferences. Eric Schadt, CEO, and Isaac Ro, CFO, will engage in fireside chats on September 10 at 8:40 a.m. ET during the Wells Fargo Securities Healthcare Conference and on September 13 at 9:30 a.m. ET at the Morgan Stanley 19th Annual Global Healthcare Conference. Live and recorded webcasts will be accessible through Sema4's investor relations website.

Sema4 focuses on patient-centered health intelligence, leveraging AI to enhance healthcare through comprehensive data analysis.

Positive
  • None.
Negative
  • None.

STAMFORD, Conn., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that Eric Schadt, Ph.D., Founder and Chief Executive Officer, and Isaac Ro, Chief Financial Officer will participate at the following virtual investor conferences:

  • Wells Fargo Securities Healthcare Conference
    Fireside chat on Friday, September 10th at 8:40 a.m. ET
  • Morgan Stanley 19th Annual Global Healthcare Conference
    Fireside chat on Monday, September 13th at 9:30 a.m. ET

Live and archived webcasts of the events will be available on the “Events” section of the Sema4 investor relations website at https://ir.sema4.com/.

About Sema4

Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Centrellis™, our innovative health intelligence platform, is enabling us to generate a more complete understanding of disease and wellness and to provide science-driven solutions to the most pressing medical needs. Sema4 believes that patients should be treated as partners, and that data should be shared for the benefit of all.

For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube.

Investor Relations Contact:
Joel Kaufman
Sema4
investors@sema4.com

Media contact:
Radley Moss
Sema4
radley.moss@sema4.com


FAQ

When will Sema4 participate in the Wells Fargo Securities Healthcare Conference?

Sema4 will participate in the Wells Fargo Securities Healthcare Conference on September 10 at 8:40 a.m. ET.

What is the date for Sema4's appearance at the Morgan Stanley Global Healthcare Conference?

Sema4 will appear at the Morgan Stanley 19th Annual Global Healthcare Conference on September 13 at 9:30 a.m. ET.

How can I access the webcasts of Sema4's investor conferences?

Live and archived webcasts of Sema4's investor conferences can be found in the 'Events' section of their investor relations website.

What is the focus of Sema4 as a health intelligence company?

Sema4 is dedicated to advancing healthcare through AI and machine learning, applying these technologies to clinical and genomic data to improve health outcomes.

What are the stock symbols for Sema4?

The stock symbols for Sema4 are SMFR and SMFRW.

SMFR

:SMFR

SMFR Rankings

SMFR Latest News

SMFR Stock Data

120.14M